Actively Recruiting
Development of Isthmocele Symptom Severity and Quality of Life Scale
Led by Hilal Yuvacı · Updated on 2024-08-20
330
Participants Needed
1
Research Sites
156 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Isthmocele, also known as cesarean scar defect (CSD), is the disruption of the integrity of the myometrium in the cesarean section incision and the indentation of the opening in the myometrium towards the visceral peritoneum. Residual menstrual blood accumulating in the isthmocele sac can cause chronic endometritis, anormal uterine bleeding, infertility and chronic pelvic pain. There is currently no quality of life scale that assesses isthmocele symptoms. A scale is needed to determine the positive effect on the patient's quality of life after the surgeries are performed. This study it is aimed to develop a scale that evaluates the severity of isthmocele symptoms and the impact on quality of life due to isthmocele.
CONDITIONS
Official Title
Development of Isthmocele Symptom Severity and Quality of Life Scale
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients with isthmocele symptoms three months after cesarean delivery will be included in the study.
You will not qualify if you...
- Findings that may be confused with isthmocele symptoms, such as uterine fibroids and endometrial polyps, exclude participation.
- Patients with acute vaginitis and pelvic inflammatory disease will not be included in the study.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Sakarya University School of Medicine
Sakarya, Turkey (Türkiye)
Actively Recruiting
Research Team
H
Hilal Uslu Yuvacı
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here